Functionalized Nanomaterials for the Management of Microbial Infection: A Strategy to Address Microbial Drug Resistance introduces the reader to the newly developing use of nanotechnology to combat microbial drug resistance. Excessive use of antibiotics and antimicrobial agents has produced an inexorable rise in antibiotic resistance in bacterial pathogens. The use of nanotechnology is currently the most promising strategy to overcome microbial drug resistance. This book shows how, due to their small size, nanoparticles can surmount existing drug resistance mechanisms, including decreased uptake and increased efflux of the drug from the microbial cell, biofilm formation, and intracellular bacteria. In particular, chapters cover the use of nanoparticles to raise intracellular antimicrobial levels, thus directly targeting sites of infection and packaging multiple antimicrobial agents onto a single nanoparticle.

N� de ref. del art�culo LU-9780323416252

Contactar al vendedor

Denunciar este art�culo

Detalles bibliogr�ficos

T�tulo: Functionalized Nanomaterials for the Management of Microbial Infection
Editor: Elsevier - Health Sciences Division, US
Fecha de publicaci�n: 2017
Idioma: Ingl�s
ISBN 10: 032341625X
ISBN 13: 9780323416252
Encuadernaci�n: Hardback
Estado: New
Peso: 1250 gramos

Acerca de

Sinopsis

Functionalized Nanomaterials for the Management of Microbial Infection: A Strategy to Address Microbial Drug Resistance introduces the reader to the newly developing use of nanotechnology to combat microbial drug resistance. Excessive use of antibiotics and antimicrobial agents has produced an inexorable rise in antibiotic resistance in bacterial pathogens.

The use of nanotechnology is currently the most promising strategy to overcome microbial drug resistance. This book shows how, due to their small size, nanoparticles can surmount existing drug resistance mechanisms, including decreased uptake and increased efflux of the drug from the microbial cell, biofilm formation, and intracellular bacteria. In particular, chapters cover the use of nanoparticles to raise intracellular antimicrobial levels, thus directly targeting sites of infection and packaging multiple antimicrobial agents onto a single nanoparticle.

Provides the information users need to integrate antibacterial nanoparticles into future treatments
Gives readers with backgrounds in nanotechnology, chemistry, and materials science an understanding of the main issues concerning microbial drug resistance and its challenges
Includes real-life case studies that illustrates how functionalized nanomaterials are used to manage microbial infection

Acerca de los autores

Rabah Boukherroub is Research Director Group Leader at the Institute of Electronics, Microelectronics and Nanotechnology, University of Lille, France. His research interests are in the area of synthesis of functional nanomaterials (metal and semiconductor nanoparticles, semiconductor nanowires, graphene, carbon dots, etc.), surface chemistry, and photophysics of semiconductor/metal nanostructures with emphasis on biosensors and lab-on-chip applications, drug delivery, and development of new tools for studying molecular dynamics in vivo.

Sabine Szunerits is since 2009 Professor in Chemistry at the University Lille 1, France and was nominated 2011 as member of the “Institut universitaire de France� (IUF). Her current research interests are in the area of material science with emphasis on the development of novel analytical platforms and interfaces for the study of affinity binding events and in the modification of nanostructures (diamond particles, magnetic particles, nanographene) for biomedical applications. She is co-author of more than 230 research publications, wrote several book chapters and has 6 patents

Djamel Drider is full professor of Microbiology at Lille 1 University Sciences and Technologies. D. Drider obtained his PhD from Montpellier School of Agriculture and completed his postdoctoral training at Centro de Investigaciones Biologicas (Madrid, Spain) and Mount Sinai School of Medicine of New York University (USA). D. Drider was hired as Associate Professor at Nantes-Atlantic College of Veterinary Medicine; Food Science and Engineering (France). His research is mainly dedicated to antimicrobial peptides mainly those produced by lactic acid bacteria (bacteriocins).

"Sobre este t�tulo" puede pertenecer a otra edici�n de este libro.

Descripci�n de la librer�a

Ver la p�gina web de la librer�a

Informaci�n empresarial del vendedor

RAREWAVES.COM LIMITED
Elsley Court, 20-22 Great Titchfield Street, London, W1W 8BE, United Kingdom

Condiciones de venta y env�o

Condiciones de venta

Derecho a cancelaci�n

Condiciones de env�o

Please note that we do not offer Priority shipping to any country.

We currently do not ship to the below countries:

Russia
Belarus
Ukraine
Israel

Please do not attempt to place orders with any of these countries as a ship to address - they will be cancelled.

Tarifas de env�o de Reino Unido a Estados Unidos de America

Tarifas de env�o de Reino Unido a Estados Unidos de America
Cantidad del pedido	De 9 a 14 d�as h�biles	De 9 a 14 d�as h�biles
Primer art�culo	EUR 0.00	EUR 0.00

Los plazos de entrega los establecen los vendedores y var�an seg�n el transportista y la ubicaci�n. Los pedidos que pasan por la aduana pueden sufrir retrasos y los compradores son responsables de los aranceles o tarifas asociadas. Los vendedores pueden ponerse en contacto con usted en relaci�n con cargos adicionales para cubrir cualquier aumento en los costes de env�o de los art�culos.